Category: US Chamber of Commerce

Comparing the Metrics on China and Intellectual Property

China’s success in meeting IP-related metrics highlights a broader challenge for comparative ranking systems: they often measure what is easiest to quantify—such as patent and trademark filings—rather than how IP systems actually function in practice. While China has shifted from quantity to “quality”-oriented indicators, these remain metric-driven and closely tied to national planning goals, including commercialization, industrial output, and global portfolio development. By contrast, indices like the U.S. Chamber’s International IP Index and the World Justice Project emphasize legal and institutional conditions, but may underweight how effectively private rights are enforced in real-world settings. A more balanced approach would focus on the operation of civil remedies, transparency across all forms of enforcement, treatment of foreign and domestic actors, the functioning of private licensing markets, and the system’s responsiveness to new technologies—areas that are harder to quantify but more indicative of a well-functioning IP system.

Patent Litigation, IP Monetization and Technology Decoupling: Lessons for the Future

Even during a time of trade conflict, there was considerable litigation and patent licensing activity with China, including a pronounced role in global markets for Chinese companies and in China for US companies. Patent disputes and licensing involved a diverse group of technologies. Chinese companies have become more active in SEP litigation overseas. The United States is an important venue for litigating overseas patent disputes with Chinese entities. Both the patent licensing and pharma data show the importance of tracking market value and trends to determine the real-world impact of IP-related policies.